- Home
- ADPT vs UAN Comparison
ADPT vs UAN Comparison
Compare ADPT & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- UAN
- Stock Information
- Founded
- ADPT 2009
- UAN 2007
- Country
- ADPT United States
- UAN United States
- Employees
- ADPT N/A
- UAN N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- UAN Agricultural Chemicals
- Sector
- ADPT Health Care
- UAN Industrials
- Exchange
- ADPT Nasdaq
- UAN Nasdaq
- Market Cap
- ADPT 929.8M
- UAN 793.5M
- IPO Year
- ADPT 2019
- UAN 2011
- Fundamental
- Price
- ADPT $6.81
- UAN $83.98
- Analyst Decision
- ADPT Buy
- UAN
- Analyst Count
- ADPT 4
- UAN 0
- Target Price
- ADPT $6.75
- UAN N/A
- AVG Volume (30 Days)
- ADPT 1.3M
- UAN 38.5K
- Earning Date
- ADPT 02-12-2025
- UAN 02-18-2025
- Dividend Yield
- ADPT N/A
- UAN 7.97%
- EPS Growth
- ADPT N/A
- UAN N/A
- EPS
- ADPT N/A
- UAN 4.97
- Revenue
- ADPT $177,282,000.00
- UAN $527,388,000.00
- Revenue This Year
- ADPT $6.48
- UAN N/A
- Revenue Next Year
- ADPT $18.72
- UAN N/A
- P/E Ratio
- ADPT N/A
- UAN $16.87
- Revenue Growth
- ADPT N/A
- UAN N/A
- 52 Week Low
- ADPT $2.28
- UAN $61.62
- 52 Week High
- ADPT $7.46
- UAN $88.94
- Technical
- Relative Strength Index (RSI)
- ADPT 54.92
- UAN 75.90
- Support Level
- ADPT $5.98
- UAN $74.21
- Resistance Level
- ADPT $7.28
- UAN $84.96
- Average True Range (ATR)
- ADPT 0.54
- UAN 2.24
- MACD
- ADPT -0.00
- UAN 0.83
- Stochastic Oscillator
- ADPT 58.06
- UAN 91.25
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.